Notes / Company

Colinz Laboratories Ltd.

COLINZ BSE 531210 ISIN INE923C01011 Pharmaceuticals

Fundamentals

Market cap: ₹11 cr
P/E: 22.68×
ROE: 5.24%
Debt / equity: 0.07
52-week range: 36.11 — 87.91

The timeline — 1 note on Colinz Laboratories Ltd.

May 2026

25 May 26 · 1:44 PM IST Alert

Alert

Colinz Laboratories promoter dumps 15% stake in off-market sale

Vijaya Mani cut her holding from 49.56% to 34.56% in a single transaction. The sale represents roughly 15% of the company's total market value.

Verify on exchange BSE filings for COLINZ NSE filings for COLINZ